Commentary: Regression discontinuity design: Let's give it a try to evaluate medical and public health interventions

Epidemiology

Volumn 25, Issue 5, 2014, Pages 738-741

  Vandenbroucke, Jan P ^a   Le Cessie, Saskia ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; EPIDEMIOLOGICAL DATA; HEALTH CARE; HEALTH CARE DELIVERY; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; LINEAR REGRESSION ANALYSIS; MEASUREMENT ERROR; NORMAL DISTRIBUTION; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION DISCONTINUITY DESIGN; STUDY DESIGN; EPIDEMIOLOGY; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

CAUSALITY; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MODELS, STATISTICAL; REGRESSION ANALYSIS;

EID: 84905486067     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000145     Document Type: Note

References (13)

1. Rubin DB. Assignment to treatment group on the basis of a covariate. J Educ Stat. 1977;2:1-26.
2. Trochim W. The regression-discontinuity design. In: Agency for Health Care Policy and Research Conference Proceedings: Research Methodology: Strengthening Causal Interpretations of Nonexperimental Data. Washington, D.C.: U.S. Department of Health and Human Services; 1990.
3. Finkelstein MO, Levin B, Robbins H. Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal. Am J Public Health. 1996;86:691-695.
4. Finkelstein MO, Levin B, Robbins H. Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples. Am J Public Health. 1996;86:696-705.
5. Bor J, Moscoe E, Mutevedzi P, Newell ML, Bärnighausen T. Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology. 2014;25:729-737
6. Zuckerman IH, Lee E, Wutoh AK, Xue Z, Stuart B. Application of regression-discontinuity analysis in pharmaceutical health services research. Health Serv Res. 2006;41:550-563.
7. Boot CPM. Risicofactoren Voor Coronaire Hartziekten. Screening En Interventie In Een Huisartspraktijk. Proefschrift, Leiden 1979. (Risk Factors For Coronary Heart Disease. Screening and Intervention in One General Practice). Leiden, Netherlands: University of Leiden; 1979.
8. Sara Geneletti, Aidan G. O'Keefe, Linda D. Sharples, Sylvia Richardson, and Gianluca Baio. Bayesian regression discontinuity designs: Incorporating clinical knowledge in the causal analysis of primary care data. Available at: http://arxiv.org/pdf/1403.1806v1.pdf Accessed 28 March 2014.
9. Galton F. Regression towards mediocrity in hereditary stature. The Journal of the Anthropological Institute of Great Britain and Ireland. 1886;15:246-263. Available at: http://www.stat.ucla.edu/~nchristo/ statistics100C/history-regression.pdf Accessed 28 March 2014.
10. Linden A, Adams JL, Roberts N. Evaluating disease management programme effectiveness: an introduction to the regression discontinuity design. J Eval Clin Pract. 2006;12:124-131.
11. Stanley TD, Robinson A. Sifting statistical significance from an artefact of regression-discontinuity design. Evaluation Review. 1990;14:166-181.
12. Cappelleri JC, Trochim WMK, Stanley TD, Reichardt CS. Random measurement error does not bias the treatment effect estimate in the regression- discontinuity design: I. the case of no interaction. Evaluation Review. 1991;19:395-419.
13. Reichardt CS, Trochim W, Cappelleri J. Reports of the death of the regression-discontinuity design are greatly exaggerated. Evaluation Review. 1995;19:39-63.